期刊文献+

脓毒症患者血中CD4^+CD25^+调节性T细胞水平检测的临床意义 被引量:12

Clinical Implications of Blood CD4^+CD25^+ Regulatory T cells in Patients with Sepsis
下载PDF
导出
摘要 目的探讨脓毒症患者血中CD4+CD25+调节性T细胞(Treg细胞)的水平与机体细胞免疫状态的关系及其对预后的评估价值。方法纳入2007年8月至2008年8月ICU病房的脓毒症患者为病例组(n=27),健康查体者为对照组(n=40)。再将脓毒症患者根据28d预后分为死亡组(n=8)和存活组(n=19)。应用流式细胞仪技术检测Treg%、CD4/CD8。以硝酸银染色,应用图像分析系统计算核仁银染面积与核面积的比值(IS%)。结果脓毒症患者血中Treg%明显高于对照组[(5.61±1.60)%比(0.78±0.23)%,P<0.01],CD4/CD8和IS%明显低于对照组[CD4/CD8:(1.09±0.30)比(1.71±0.36);IS%:(5.19±1.07)%比(6.76±0.92%;P均<0.01]。Treg%与CD4/CD8、IS%呈显著负相关(r值分别为-0.484和-0.588,均P<0.01)。死亡组血中Treg%水平明显高于存活组[(7.09±1.17)%比(5.00±1.33)%,P<0.01],CD4/CD8、IS%明显低于存活组[CD4/CD8:(0.87±0.22)比(1.18±0.29);IS%:(3.97±0.42)%比(5.71±0.81)%;P均<0.01]。结论脓毒症患者血中Treg%水平可以反映细胞免疫状态,对评估患者预后有临床价值。 Objective To investigate the relationship between blood CD4+CD25+ regulatory T cells (Treg cells) and cell immunity in patients with sepsis and its prognostic value.Methods 27 patients with sepsis admitted during August 2007 and August 2008 in ICU were enrolled,while 40 healthy volunteers served as control.According to the clinical outcome after 28 days’ treatment,the sepsis patients were assigned to a death group(n=8) and a survival group (n=19).Blood Treg% and CD4/CD8 were detected by flow cytometry and total AgNOR area/nucleus area per cell (IS%) was measured by silver nitrate staining and image processing.Results The Treg% in the patients with sepsis was significant higher than that in the normal control [(5.61±1.60)% vs.(0.78±0.23)%,P0.01],while the level of CD4/CD8 and IS% were significant lower[CD4/CD8:(1.09±0.30) vs.(1.71±0.36),IS%:(5.19±1.07)% vs.(6.76±0.92)%,both P0.01].Significant correlations were found between Treg% and CD4/CD8(r=-0.484,P0.01),and between Treg% and IS% (r=-0.588,P0.01).Compared with the survival group,Treg% was significant higher [(7.09±1.17)% vs.(5.00±1.33)%,P0.01],and CD4/CD8 and IS% were significant lower[CD4/CD8:(0.87±0.22) vs.(1.18±0.29),IS%:(3.97±0.42)% vs.(5.71±0.81)%,both P0.01] in the death group.Conlusion Blood Treg% level can reflect the cell immune state of patients with sepsis and is of clinical value to assess the prognosis.
出处 《中国呼吸与危重监护杂志》 CAS 2010年第4期416-418,共3页 Chinese Journal of Respiratory and Critical Care Medicine
关键词 脓毒症 调节性T细胞 细胞免疫 Sepsis Regulatory T cells Cell immunity
  • 相关文献

参考文献10

  • 1Andrews P, Azoulay E, Antonelli M, et al. Year in review in Intensive Care Medicine, 2006. II. hffections and sepsis, haemodynamics, elderly, invasive and noninvasive mechanical ventilation, weaning, ARDS. Intensive Care Med, 2007,33 : 214- 229.
  • 2崔德健.探讨脓毒症诊断和治疗新策略[J].中国呼吸与危重监护杂志,2004,3(3):131-133. 被引量:4
  • 3Shimizu J, Yamazaki S, Takahashi T, et al. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self- tolerance. Nat Immuno1,2002,3 : 135-142.
  • 4Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS international sepsis definitions conference. Crit Care Med, 2003,31 : 1250-1256.
  • 5Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic selftolerance maintained by cell expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune disease. Immunol, 1995,155,1151-1164.
  • 6Wisnoski N, Chung CS, Chen Y. The Contribution of CD4+ CD25 + T-Regulatory-Cells to immune suppression in sepsis. Shock, 2007, 27:251-257.
  • 7Monneret G, Debard AL, Venet F,et al. Marked elevation of human circulating CD4+ CD25+ regulatory T cells in sepsis induced immunoparalysis. Crit Care Med ,2003,31:2068-2071.
  • 8Von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat hnmuno1,2005 ,6 :338-344.
  • 9Venet F,Pachot A,Debard AL. Human CD4+ CD25 + Regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J Immunol,2006, 177:6540-6547.
  • 10Heuer JG, Zhang T, Zhao J, etal. Adoptive transfer of in vitro stimulated CD4+ CD25 + regulatory T cells increases bacterial clearance and improves survival in polymierobial sepsis. J Immunol, 2005,174:7141-7146.

二级参考文献14

  • 1Czermak BJ,Sarma V,Pierson CL,et al.Protective effects of C5a blockade in sepsis.Nat Med,1999;5:788-792
  • 2Coopersmith CM,Stromberg PE,Dunne WM,et al.Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis.JAMA,2002;287:1716-1721
  • 3Rivers E,Nguyen B,Havstad S,et al.Early goal-directed therapy in the treatment of severe sepsis and septic shock.N Eng J Med,2001;345:1368-1377
  • 4Van den Berghe G,Wouters P,Weekers F,et al.Intensive insulin therapy in the critically ill patients.N Eng J Med,2001;345:1359-1367
  • 5Fitch JC,Rollins S,Matis L,et al.Pharmacology and biological efficacy of a recombinant,humanized,single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.Circulation,1999;100:249
  • 6Riedemann NC,Guo RF,Ward PA.The enigma of sepsis.J Clin Invest,2003;112:460-467
  • 7Martin GS,Mannino DM,Eaton S,et al.The epidemiology of sepsis in the United States from 1979 through 2000.N Eng J Med,2003;348:1546-1554
  • 8Riedemann NC,Guo RF,Ward PA.Novel strategies for the treatment of sepsis.Nat Med,2003;9:517-524
  • 9Bone RC,Sprung CL,Sibbald WJ.Definitions for sepsis and organ failure.Crit Care Med,1992;20:724-726
  • 10Levy MM,Fink MP,Marshall JC,et al.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.Crit Care Med,2003;31:1250-1256

共引文献3

同被引文献86

引证文献12

二级引证文献168

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部